At @DanaFarber, we envision a world free from the fear and burden of cancer. We are very proud to advance our collaboration with Oncoclínicas to help improve cancer care in Brazil. https://t.co/aMT7rBdXnB
The 23Q2 data release is live on https://t.co/dQjWYpg0CG! We are excited to share new CRISPR and omics data, an update in our CRISPR method, Chronos, a new Target Discovery app and a new cell line page. #DepMapPortal#DepMap#OpenScience#CancerResearch
A thread about something beautiful.
On our last vacation, our daughters made friends with two other amazing girls. We began to hangout with their parents, Kevin and Rachel. Rachel introduced herself by saying that she was an artist.
We are thrilled that patients with metastatic HR+, HER2- breast cancer now have a promising treatment option following the FDA's approval a novel antibody drug-conjugate therapy based on a study led by @stolaney1. https://t.co/HgDhgAIImN
So excited to share our work on the genetic architecture of rare coding variation, now published in @Nature
https://t.co/Ya88qj01nD
This work was led by superstar co-first authors @danweiner92 and @NadigAjay
At Dana-Farber our world-class researchers and clinicians are working to end cancer as we know it. We join with @potus and @flotus to make this goal a reality.
Applications are now open for the 2023 Angelika Amon Young Scientist Awards.
The prize is awarded to grad students studying life sciences or biomedical research outside the U.S. who embody Dr. Amon’s infectious enthusiasm for discovery science.
https://t.co/c3pYjMwkvG
A new generation of cancer-preventing vaccines could wipe out tumors before they form.
Learn more on #WorldCancerDay: https://t.co/RLU0uUwdRq @ScienceVisuals
Really nice spotlight article about our work on TBK1 as an immunotherapy target in @TrendsImmuno by @FitzgeraldKate and @MichelleKellih3 . Thanks for writing up this nice summary! Original article here: https://t.co/S2HF0IJkmL
The Mulvaney Lab will launch this Fall in DC! I’m excited to start my tenure-track position at Fralin Biomedical Research Institute, Virginia Tech Carilion School of Medicine with dual membership at the Cancer & Immunology Research Center of Children’s National Hospital.
Every child who fights cancer is a hero. They endure pokes, hospitalizations, experimental treatments, side effects. All in addition to the harsh symptoms of cancer itself. Yet they smile, love, find joy. They teach us what being strong means. Sometimes, even after they're gone.
CAR T in solid tumors: A 31-year-old with sDMG has experienced a near-complete (>95%) reduction in tumor volume and a 17-year-old with DIPG experienced a near-complete (>98%) reduction in volume of a pontine tumor. https://t.co/ILOeAO9J8I
We asked what would happen if we flipped a research paradigm and partnered with prostate cancer patients to bring genomics research to them
At their doorsteps
Wherever they live...
@jettcrowdis@DanaFarber@broadinstitute@EmCollective@CellGenomics [1/n] https://t.co/WROlYNfXzP
We’re very proud that President Biden has chosen Dr. Monica Bertagnolli to lead the NCI. She is an eminent surgeon with extensive clinical and leadership experience. Monica will be a superb leader at the NCI at a time when cancer research is so promising. https://t.co/WkAYKDGAMk